Trastuzumab and heart damage

Abstract

Trastuzumab therapy and the risk of cardiotoxicity, cardiac dysfunction, high body mass index (BMI) and drug treatment of hypertension.

Keywords

• Trastuzumab
• BMI
• anthracycline
• cardiotoxicity
• heart failure